TSE:TLT Stock Latest News
Company AnnouncementsTheralase Posts Strong Bladder Cancer Data and Targets 2027 Regulatory Milestones6d ago
Company AnnouncementsTheralase Narrows Loss and Expands Bladder Cancer Trial with Ferring1M ago
Company AnnouncementsTheralase Launches GLP Toxicology Program for Rutherrin Cancer Therapy1M ago
Company AnnouncementsTheralase Narrows Loss, Bolsters Cash as Bladder Cancer Trial Advances2M ago
Company AnnouncementsTheralase Raises C$3.6 Million to Advance Cancer and Antiviral Pipeline2M ago
Company AnnouncementsTheralase launches up to C$5 million LIFE financing to advance cancer and antiviral pipeline2M agoCompany AnnouncementsTheralase Posts 100% Preclinical Response in Muscle Invasive Bladder Cancer Study6M ago
- Company AnnouncementsTheralase Raises C$2.66 Million to Advance Bladder Cancer Drug Programs6M ago
- Company AnnouncementsTheralase Uncovers New Antiviral Mechanism for Ruvidar Against Herpes Virus7M ago
- Company AnnouncementsTheralase Raises C$1.1 Million to Advance Bladder Cancer Trial7M ago
- Company AnnouncementsTheralase’s Rutherrin Boosts Radiation Efficacy in Muscle Invasive Bladder Cancer Models7M ago
Company AnnouncementsTheralase Preclinical Data Backs Ruvidar–Interferon Combo for Bladder Cancer8M ago
Company AnnouncementsTheralase Preclinical Data Backs Ruvidar–Interferon Combo in Bladder Cancer8M ago
Company AnnouncementsTheralase Bladder Cancer Data Heads to Major Urology Congress as Regulatory Plans Advance8M ago
- Company AnnouncementsTheralase Bladder Cancer Data to Headline 2026 European Urology Congress8M ago
- Company AnnouncementsTheralase Bladder Cancer Data to Debut at 2026 European Urology Congress8M ago
- Company AnnouncementsTheralase Bladder Cancer Data Heads to Key Urology Conference as Regulatory Filings Near8M ago
- Company AnnouncementsTheralase’s Bladder Cancer Therapy Exceeds Key Benchmarks in Phase II Trial9M ago
Company AnnouncementsTheralase Hits Key Enrollment Milestone in Phase II Bladder Cancer Trial9M ago
Company AnnouncementsTheralase and Ferring Launch Combination Trial for BCG-Unresponsive Bladder Cancer9M ago
